Scarica l'app Stockscreener
5.56
13.93%
0.68
Dopo l'orario di chiusura:
5.60
0.04
+0.72%
Precedente Chiudi:
$4.88
Aprire:
$4.93
Volume 24 ore:
1.11M
Relative Volume:
2.01
Capitalizzazione di mercato:
$186.69M
Reddito:
-
Utile/perdita netta:
$-14.14M
Rapporto P/E:
-6.0435
EPS:
-0.92
Flusso di cassa netto:
$-12.64M
1 W Prestazione:
+30.82%
1M Prestazione:
+82.30%
6M Prestazione:
+153.88%
1 anno Prestazione:
+120.63%
Intervallo 1D:
$4.75
$5.57
Intervallo di 1 settimana:
$3.78
$5.57
Portata 52W:
$1.34
$5.57
Immix Biopharma Inc Stock (IMMX) Company Profile
Nome
Immix Biopharma Inc
Settore
Industria
Telefono
(888) 958-1084
Indirizzo
11400 WEST OLYMPIC BLVD., LOS ANGELES
Confronta IMMX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
5.56 | 162.52M | 0 | -14.14M | -12.64M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immix Biopharma Inc Borsa (IMMX) Ultime notizie
Is Immix Biopharma Inc (IMMX) positioned for future growth? - Setenews
Immix Biopharma, Inc.'s (NASDAQ:IMMX) market cap rose US$18m last week; retail investors who hold 56% profited and so did insiders - simplywall.st
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher – What’s Next? - Defense World
What analysts say about Immix Biopharma Inc stockSector Rotation Strategies & Our Experts Decode Market Noise for You - earlytimes.in
Is Immix Biopharma Inc a good long term investmentMarket Depth Overview & Watch and Learn From Live Trades - earlytimes.in
Will Immix Biopharma Inc. stock benefit from automationJuly 2025 Catalysts & Accurate Intraday Trade Tips - BỘ NỘI VỤ
Immix Biopharma appoints Michael Grabow as chief commercial officer to drive NXC-201 launch - MSN
A significant driver of top-line growth: Immix Biopharma Inc (IMMX) - Setenews
Immix Biopharma Updates Accounting Firm Consents - MSN
Immix Biopharma files updated auditor consents for SEC registration statement - Investing.com Nigeria
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Immix Biopharma Updates Auditor Consents for Registration Statement - TradingView
[8-K] Immix Biopharma, Inc. Reports Material Event | IMMX SEC FilingForm 8-K - Stock Titan
Is Variman Global Enterprises Limited Worth Holding Through Market ReversalDividend Cut Warnings & Low Cost Capital Trading - earlytimes.in
We Think Immix Biopharma (NASDAQ:IMMX) Needs To Drive Business Growth Carefully - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Will Immix Biopharma Inc. stock rally after Fed decisionsQuarterly Risk Review & Real-Time Buy Zone Alerts - newser.com
Working capital per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Can trapped investors hope for a rebound in Immix Biopharma Inc.July 2025 Recap & High Conviction Buy Zone Picks - newser.com
How rising interest rates impact Immix Biopharma Inc. stockPortfolio Value Report & Weekly Hot Stock Watchlists - newser.com
Immix Biopharma’s NXC-201 CAR-T Study: A Potential Game-Changer for AL Amyloidosis - MSN
Will Immix Biopharma Inc. see short term momentum2025 Winners & Losers & Verified Swing Trading Watchlists - newser.com
How Immix Biopharma Inc. stock valuations compare to rivalsJuly 2025 Trends & Safe Capital Growth Tips - newser.com
ETFs Investing in Immix Biopharma, Inc. Stocks - TradingView
What the charts say about Immix Biopharma Inc. todayMarket Rally & AI Enhanced Execution Alerts - newser.com
How Immix Biopharma Inc. stock reacts to bond yieldsPortfolio Performance Summary & Short-Term High Return Ideas - newser.com
Immix Biopharma Inc. stock trendline breakdownEarnings Trend Report & Weekly High Conviction Ideas - newser.com
Immix Biopharma Inc Stock Analysis and ForecastEarnings Beat Highlights & Free Expert Guidance For Growth - earlytimes.in
Why Immix Biopharma Inc. stock appeals to dividend seekers2025 Top Gainers & Daily Profit Maximizing Tips - newser.com
Will Immix Biopharma Inc. stock sustain high P E ratiosEarnings Trend Report & Consistent Income Trade Recommendations - Fundação Cultural do Pará
A History of Outperforming Analyst Forecasts and Beating the Odds: Immix Biopharma Inc (IMMX) - Setenews
Best Biotech Stocks Right Now • Updated Daily - Benzinga
Risk adjusted return profile for Immix Biopharma Inc. analyzedJuly 2025 Price Swings & Capital Efficient Trade Techniques - newser.com
Immix Biopharma appoints Grabow as Chief Commercial Officer - MSN
EBIT per share of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma Inc Azioni (IMMX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.44%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):